{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T18:19:19Z","timestamp":1770488359829,"version":"3.49.0"},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.8660-16","type":"journal-article","created":{"date-parts":[[2017,9,24]],"date-time":"2017-09-24T22:08:04Z","timestamp":1506290884000},"page":"71-74","source":"Crossref","is-referenced-by-count":10,"title":["Cholesterol Crystal Embolism Induced by Direct Factor Xa Inhibitor: A First Case Report"],"prefix":"10.2169","volume":"57","author":[{"given":"Hideaki","family":"Oka","sequence":"first","affiliation":[{"name":"Division of Kidney Center, Matsuyama Red Cross Hospital, Japan"},{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Kamimura","sequence":"additional","affiliation":[{"name":"Division of Kidney Center, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Division of Kidney Center, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kento","family":"Fukumitsu","sequence":"additional","affiliation":[{"name":"Division of Kidney Center, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Iwata","sequence":"additional","affiliation":[{"name":"Division of Kidney Center, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Kondo","sequence":"additional","affiliation":[{"name":"Division of Kidney Center, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Hirashima","sequence":"additional","affiliation":[{"name":"Division of Kidney Center, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seishi","family":"Aihara","sequence":"additional","affiliation":[{"name":"Division of Kidney Center, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsumi","family":"Harada","sequence":"additional","affiliation":[{"name":"Division of Kidney Center, Matsuyama Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Tsuruya","sequence":"additional","affiliation":[{"name":"Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan"},{"name":"Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","first-page":"1509","author":"MA Creager","year":"2008","unstructured":"1. Creager MA, Libby P. Peripheral arterial diseases. In: Heart Disease. 8th edition. Braunwald E, Ed. Saunders, Philadelphia, 2008: 1509-1511.","journal-title":"Heart Disease","ISSN":"https:\/\/id.crossref.org\/issn\/1521-737X","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tan J, Afzal I, Yeadon A, Bird N, Gouldesbrough D, Akbani H. Spontaneous cholesterol embolisation causing acute renal failure. Clin Exp Nephrol 11: 235-237, 2007.","DOI":"10.1007\/s10157-007-0482-7"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Enomae M, Takeda S, Yoshimoto K, Takagawa K. Chronic cholesterol crystal embolism with a spontaneous onset. Intern Med 46: 1123-1126, 2007.","DOI":"10.2169\/internalmedicine.46.0102"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bradley M. Images in clinical medicine. Spontaneous atheroembolism. N Engl J Med 332: 998, 1995.","DOI":"10.1056\/NEJM199504133321505"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Rindone JP, Mellen CK, Eliason JD. Late onset purple toe syndrome with warfarin successfully treated with fondaparinux. Am J Ther 18: e277-e279, 2011.","DOI":"10.1097\/MJT.0b013e3181df8e0a"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cakebread HE, Knight HM, Gajendragadkar PR, Cooper JP. Warfarin-induced purple toe syndrome successfully treated with apixaban. BMJ Case Rep: 2014.","DOI":"10.1136\/bcr-2014-205320"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hyman BT, Landas SK, Ashman RF, Schelper RL, Robinson RA. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 82: 1233-1237, 1987.","DOI":"10.1016\/0002-9343(87)90231-2"},{"key":"8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.35.5.946","volume":"35","author":"M Moldveen-Geronimus","year":"1967","unstructured":"8. Moldveen-Geronimus M, Merriam JC Jr. Cholesterol embolization. From pathological curiosity to clinical entity. Circulation 35: 946-953, 1967.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"9","unstructured":"9. Donohue KG, Saap L, Falanga V. Cholesterol crystal embolization: an atherosclerotic disease with frequent and varied cutaneous manifestations. J Eur Acad Dermatol Venereol 17: 504-511, 2003."},{"key":"10","unstructured":"10. Molinos S, Feal C, G\u00e1ndara A, Morla J, De la Torre C, Ros\u00f3n E. Cholesterol emboli syndrome: significance of the lesional skin biopsies. Acta Derm Venereol 85: 527-528, 2005."},{"key":"11","unstructured":"11. Pennington M, Yeager J, Skelton H, Smith KJ. Cholesterol embolization syndrome: cutaneous histopathological features and the variable onset of symptoms in patients with different risk factors. Br J Dermatol 146: 511-517, 2002."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wassef A, Butcher K. Novel oral anticoagulant management issues for the stroke clinician. Int J Stroke 11: 759-767, 2016.","DOI":"10.1177\/1747493016660100"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Caldeira D, Rodrigues FB, Barra M, et al. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis. Heart 101: 1204-1211, 2015.","DOI":"10.1136\/heartjnl-2015-307489"},{"key":"14","unstructured":"14. Caldeira D, Canastro M, Barra M, et al. Risk of substantial intraocular bleeding with novel oral anticoagulants: systematic review and meta-analysis. JAMA Ophthalmol 133: 834-839, 2015."},{"key":"15","unstructured":"15. Caldeira D, Barra M, Ferreira A, et al. Systematic review with meta-analysis: the risk of major gastrointestinal bleeding with non-vitamin K antagonist oral anticoagulants. Aliment Pharmacol Ther 42: 1239-1249, 2015."},{"key":"16","unstructured":"16. Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M. Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and Meta-Analysis. Circulation 132: 194-204, 2015."},{"key":"17","unstructured":"17. Feder W, Auerbach R. "Purple toes": an uncommon sequela of oral coumarin drug therapy. Ann Intern Med 55: 911-917, 1961."},{"key":"18","unstructured":"18. Y\u00fccel AE, Kart-K\u00f6seoglu H, Demirhan B, Ozdemir FN. Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases. Rheumatol Int 26: 454-460, 2006."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nakayama M, Nagata M, Hirano T, et al. Low-dose prednisolone ameliorates acute renal failure caused by cholesterol crystal embolism. Clin Nephrol 66: 232-239, 2006.","DOI":"10.5414\/CNP66232"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Mann S, Sos TA. Treatment of atheroembolization with corticosteroids. Am J Hypertens 14: 831-834, 2001.","DOI":"10.1016\/S0895-7061(01)02183-5"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/1\/57_8660-16\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T22:31:53Z","timestamp":1570141913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/1\/57_8660-16\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8660-16","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}